Oral Versus Parenteral B12 in Dogs With Chronic Enteropathy

Chee-Hoon Chang, DVM, MS, DACVIM (SAIM), PhD candidate, Texas A&M University

ArticleLast Updated June 20243 min read
Featured Image

In the Literature

Dor C, Nixon S, Schmitz SS, et al. Efficacy and tolerance of oral versus parenteral cyanocobalamin supplement in hypocobalaminaemic dogs with chronic enteropathy: a controlled randomised open-label trial. J Small Anim Pract. 2024;65(5):317-328. doi:10.1111/jsap.13705


The Research …

Cobalamin (ie, vitamin B12) is an important intracellular cofactor. Hypocobalaminemia can result in cellular cobalamin deficiency that leads to increased methylmalonic acid (MMA) concentrations, is identified in 19% to 38% of dogs with chronic enteropathy (CE), and warrants cobalamin supplementation.1-3 Parenteral administration of cyanocobalamin has been the main method of supplementation; however, recent studies have shown similar efficacy of oral and parenteral supplementation for achieving normal serum cobalamin and/or MMA concentrations.4-6

Sponsor message; content continues afterward

Trusted content.

Tailored to you.

For free.

Create an account for free.

Want free access to the #1 publication for diagnostic and treatment information? Create a free account to read full articles and access web-exclusive content on cliniciansbrief.com.

Already have an account?

To access full articles on cliniciansbrief.com, please sign in below.

Remember Me